Nirsevimab Monoclonal Antibody Memo (2024-2025)

• 2024

  Log in to bookmark this resource.

  Log in
• Lauren Puckett; Lauren Kushner; Hayden Schwenk; Shabnam Gaskari

---

Access Resources

• Job AidEN
• Ask aRCie About This Resource

About

This memo outlines recommendations and an implementation plan for nirsevimab (Beyfortus™), a long-acting monoclonal antibody effective against respiratory syncytial virus (RSV), at Lucile Packard Children’s Hospital (LPCH) Stanford and Clinics for the 2024-2025 RSV season. RSV is a common childhood viral infection that mainly affects the upper respiratory tract but can also lead to lower respiratory tract (LRT) disease and is a major cause of hospitalizations in children.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Infant; Pregnant Women; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Immunization Programs; Lung Diseases, Obstructive; Antibodies, Monoclonal, Humanized

Institutions: Lucile Packard Children's Hospital Stanford

---

More like this

Successful Implementation of Nirsevimab and Factors Influencing Uptake in Neonatal Care 2025 · Lucile Packard Children's Hospital Stanford, Stanford University Triage by Resource Allocation for INpatients [TRAIN®]: A Novel Disaster Triage Tool 2015 · Lucile Packard Children's Hospital Stanford Supporting Your Perinatal Units During COVID-19: Mental Health for Patients and Healthcare Workers 2020 · California Maternal Quality Care Collaborative, California Perinatal Quality Care Collaborative, University of California San Francisco, The NEC Society, Lucile Packard Children's Hospital Stanford

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---